Dropout is common in clinical studies, with up to half of patients leaving early due to side effects or other reasons. When dropout is informative (i.e., dependent on survival time), it introduces censoring bias, because of which treatment effect estimates are also biased. In this paper, we propose an assumption-lean framework to assess the robustness of conditional average treatment effect (CATE) estimates in survival analysis when facing censoring bias. Unlike existing works that rely on strong assumptions, such as non-informative censoring, to obtain point estimation, we use partial identification to derive informative bounds on the CATE. Thereby, our framework helps to identify patient subgroups where treatment is effective despite informative censoring. We further propose a novel model-agnostic meta-learner, called SurvB-learner, to estimate the bounds that can be used in combination with arbitrary machine-learning models, and that has favorable theoretical properties such as double-robustness and quasi-oracle efficiency. We finally demonstrate the effectiveness of our meta-learner across various experiments using both simulated and real-world data.